摘要
【摘要】 目的 对治疗肾盂肾炎患者应用头孢哌酮联合舒巴坦的效果进行探究。方法 100例肾盂肾炎患者， 随机分为对照组与观察组， 各 50例。对照组使用左氧氟沙星治疗， 观察组使用头孢哌酮联合舒巴坦治疗。对两组患者的不良反应发生情况以及临床疗效进行研究与分析。结果 观察组的治疗有效率为 88.00%， 与对照组的 40.00%相比有显著提高， 两组治疗有效率比较差异具有统计学意义（ P<0.05）。观察组的不良反应发生率为 32.00%， 与对照组的 72.00%比较有显著降低， 两组不良反应发生率比较差异具有统计学意义（ P<0.05）。结论 采取头孢哌酮联合舒巴坦治疗肾盂肾炎， 在保障患者不良反应率较低的条件下， 可有效地提高其疗效， 效果很显著， 值得医疗界的推广及其应用。
【关键词】 肾盂肾炎；头孢哌酮；舒巴坦
[Abstract] Objective To explore the effect of cefoperazone combined with sulbactam in the treatment of pyelonephritis. Methods 100 patients with pyelonephritis were randomly divided into control group and observation group, 50 cases each. The control group was treated with levofloxacin, while the observation group was treated with cefoperazone combined with sulbactam. The occurrence of adverse reactions and clinical efficacy of the two groups were studied and analyzed. Results The effective rate of treatment in the observation group was 88.00%, which was significantly higher than that in the control group (40.00%). There was a significant difference in the effective rate between the two groups (P < 0.05). The incidence of adverse reactions was 32.00% in the observation group and 72.00% in the control group. The incidence of adverse reactions in the two groups was significantly lower than that in the control group (P < 0.05). Conclusion Cefoperazone combined with sulbactam in the treatment of pyelonephritis can effectively improve the curative effect under the condition that the adverse reaction rate of patients is low, and the effect is remarkable. It is worth popularizing and applying in the medical field.
出版日期
2019年12月17日（中国期刊网平台首次上网日期，不代表论文的发表时间）
